News
Vibex MTX: The Cherry On Top Of The Antares Investment Story - Seeking Alpha
< strong > By < a href='http://seekingalpha.com/author/smith-on-stocks' > Smith On Stocks < /a > : < /strong > < p > < b > Investment Thesis < /b > < /p > < p > I initiated < a href="http://seekingalpha.com/article/312158-antares-pharmaceuticals-a-buy-based-on-exceptional-new-product-outlook" >
Ageless Radio Jan 21: Pink Ribbon Marketing, Osteoporosis, Tax Tips, Senior Cognitive Skills | PRLog
Ageless Radio Jan 21: Pink Ribbon Marketing, Osteoporosis, Tax Tips, Senior Cognitive Skills. Jan 21st Radio Show: Gayle Sulik, author of Pink Ribbon Blues; Osteoporosis; Taxability of Social Security; and Ohio State Psychologists on Seniors' Cognitive Skills. - PR11774769
Deer antlers inspire a new theory on osteoporosis
The loss of manganese could mean that calcium does not stick to bones and could cause osteoporosis. This is the new theory put forward by researchers at the University of Castilla-La Mancha in Spain after studying deer antlers. The hypothesis published this month in the Frontiers of Bioscience
FDA to Review Pfizer Inc Rheumatoid Arthritis Drug
NEW YORK, Dec 20, 2011 -- Pfizer Inc. /quotes/zigman/238207/quotes/nls/pfe PFE +1.04% announced today that the U.S. Food and Drug Administration has
US Drug Watchdog Urges All Women Who Suffered An Out Of The Blue Broken Femur Or Thighbone To Call
The US Drug Watchdog is urging women, who suffered a broken femur, or thighbone fracture, for no apparent reason, while they were using the osteoporosis drug called Fosamax to call them, and get identified. According to the FDA, "Typically these fractures occurred after using any type of
Abbott to Present Broad Spectrum of Compelling Data for HUMIRA® (Adalimumab) at American College of
Abbott to Present Broad Spectrum of Compelling Data for HUMIRA® (Adalimumab) at American College of Rheumatology Annual Scientific Meeting
Specialty Pharmaceutical Industry - 2011 Yearbook | SYS-CON MEDIA
SYS-CON Media, NJ, The world's leading i-technology media company on breaking technology news.
Lilly announces review of data on long term raloxifene treatment | Pharma Asia
Eli Lilly and Company announced that data on EVISTA (raloxifene HCl tablets) therapy for more than three years was published online in Current Medical Research & Opinion. The review includes summaries of previously published information; new, previously unpublished observations; and new data on
Osteoporosis treatment to cost £6bn by 2036 - Scotsman.com News
Osteoporosis treatment to cost £6bn by 2036 - THE cost of treating osteoporosis on the NHS is set to treble over the next 25 years unless action is taken to identify and treat people with fragile bones, a leading medical charity warns today.
Medical News: EULAR: Anti-TNF Drug Use Up Among Indigent RA Patients - in Meeting Coverage, EULAR
LONDON -- The use of biologic anti-tumor necrosis factor drugs by patients under the California Medicaid program has more than tripled since 1999, but utilization of disease-modifying drugs, such as m
Refine by Topic:
Refine by Content Type:
Refine by Source:
- www.thelancet.com (252)
- www.webmd.com (147)
- www.em-consulte.com (100)
- arthritis.webmd.com (88)
- download.thelancet.com (66)
- www.medpagetoday.com (56)
- www.prlog.org (55)
- www.biospace.com (44)
- www.australiandoctor.com.au (31)
- www.aerzteblatt.de (22)
- www.prweb.com (17)
- www.6minutes.com.au (17)
